Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Thomas

Showing results (121-130 of 237) with videos related to

Pageof 24
Sort By:
Journal of Medicinal Chemistry|March 13, 2008
Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamaseKerim Babaoglu, Anton Simeonov, John J Irwin, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitorsAmanda P Skoumbourdis, Christopher A Leclair, Eduard Stefan, et al.
Molecular Cancer Research : MCR|July 3, 2020
Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9Harri M Itkonen, Ninu Poulose, Rebecca E Steele, et al.
Leukemia|November 13, 2020
A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphomaHongbo Wang, Wei Wei, Jing-Ping Zhang, et al.
Molecular Psychiatry|June 22, 2022
The show must go on. Reply to "Distinct functions of S-ketamine and R-ketamine in mediating biobehavioral processes of drug dependency: comments on Bonaventura et al" by Insop ShimJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Molecular Psychiatry|February 23, 2022
Time will tell. Reply to "Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al." by Chen et alJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Blood Advances|January 14, 2022
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphomaAnusara Daenthanasanmak, Richard N Bamford, Makoto Yoshioka, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2022
Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell CarcinomaRoma Pahwa, Janhavi Dubhashi, Anand Singh, et al.
Molecular Psychiatry|April 16, 2021
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liabilityJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Molecular Cell|December 31, 2020
Increased demand for NAD<sup>+</sup> relative to ATP drives aerobic glycolysisAlba Luengo, Zhaoqi Li, Dan Y Gui, et al.
Pageof 24

Showing results (121-130 of 237) with videos related to

Sort By:
Pageof 24
Journal of Medicinal Chemistry|March 13, 2008
Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamaseKerim Babaoglu, Anton Simeonov, John J Irwin, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitorsAmanda P Skoumbourdis, Christopher A Leclair, Eduard Stefan, et al.
Molecular Cancer Research : MCR|July 3, 2020
Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9Harri M Itkonen, Ninu Poulose, Rebecca E Steele, et al.
Leukemia|November 13, 2020
A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphomaHongbo Wang, Wei Wei, Jing-Ping Zhang, et al.
Molecular Psychiatry|June 22, 2022
The show must go on. Reply to "Distinct functions of S-ketamine and R-ketamine in mediating biobehavioral processes of drug dependency: comments on Bonaventura et al" by Insop ShimJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Molecular Psychiatry|February 23, 2022
Time will tell. Reply to "Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al." by Chen et alJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Blood Advances|January 14, 2022
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphomaAnusara Daenthanasanmak, Richard N Bamford, Makoto Yoshioka, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2022
Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell CarcinomaRoma Pahwa, Janhavi Dubhashi, Anand Singh, et al.
Molecular Psychiatry|April 16, 2021
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liabilityJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Molecular Cell|December 31, 2020
Increased demand for NAD<sup>+</sup> relative to ATP drives aerobic glycolysisAlba Luengo, Zhaoqi Li, Dan Y Gui, et al.
Pageof 24